Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine-Reference-Cited by-同舟云学术

Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine

Published:2023-10-03 Issue:14 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Friedman Benjamin W.¹^ORCID,Solorzano Clemencia¹,Kessler Benjamin D.¹,Martorello Kristina¹,Lutz Carlo L.¹,Feliciano Carmen¹,Adler Nicole¹,Moss Hillary¹,Cain Darnell¹,Irizarry Eddie¹

Affiliation:

1. From the Department of Emergency Medicine (B.W.F., B.D.K., K.M., C.L.L., C.F., N.A., H.M., D.C., E.I.), and Pharmacy Department (C.S.), Montefiore/Einstein, Bronx, NY.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207648

Reference26 articles.

1. Current management of migraine in US emergency departments: An analysis of the National Hospital Ambulatory Medical Care Survey

2. Recurrence of Primary Headache Disorders After Emergency Department Discharge: Frequency and Predictors of Poor Pain and Functional Outcomes

3. A Randomized Trial of a Long-Acting Depot Corticosteroid Versus Dexamethasone to Prevent Headache Recurrence Among Patients With Acute Migraine Who Are Discharged From an Emergency Department

4. Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies

5. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A sequential, multiple-assignment, randomized trial of analgesic strategies for acute musculoskeletal Pain;The American Journal of Emergency Medicine;2024-08

2. Clinical guidance for choosing the right pharmacotherapy for migraine attacks;Expert Opinion on Pharmacotherapy;2024-01-02